Jubilant News
Most Popular Jubilant Story
Lilly shifts early-stage research to Indian JV
Eli Lilly has struck yet another key research collaboration deal. Anxious to push ahead with a slate of early-stage therapies, the pharma company struck a deal with India's Read more...
Latest Headlines
- October 7, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
